Last reviewed · How we verify

NCT06327204

Efficacy of Different Low Level Laser Therapy Sessions

Completed NA Last updated 25 March 2024
What this trial tests

NA trial testing 940-nm diode laser / one session in Myofascial Pain Syndrome in 90 participants. Completed in 1 December 2023.

Timeline
1 March 2023
Primary endpoint
1 October 2023
1 December 2023

Quick facts

Lead sponsorOctober 6 University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment90
Start date1 March 2023
Primary completion1 October 2023
Estimated completion1 December 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

October 6 University

Who can join

Adults 18 to 60, any sex, with Myofascial Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Myofascial pain dysfunction syndrome is one of the common causes of non-odontogenic pain in the head and neck region. It accounts for 40-60% of the adult population. Different treatment modalities had been reported to release the trigger point within the muscles of mastication in order to reduce pain and allow recovery of the function.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Efficacy of different low-level laser therapy sessions in the management of masseter muscle trigger points.
    Mahmoud NR, Shehab WI, AlAraby AA, Habaka YF. · · 2024 · cited 4× · PMID 39327563 · DOI 10.1186/s12903-024-04780-y

Verify or expand the search:

Other recruiting trials for Myofascial Pain Syndrome

Currently open trials in the same condition.

Other October 6 University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06327204.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing